July 18, 2017 — IBA (Ion Beam Applications S.A.) and Inova recently signed a contract for a two-room Proteus Plus proton therapy solution, each treatment room equipped with pencil beam scanning capability and integrated cone beam computed tomography (CBCT). Inova plans to start treating patients by 2020 at the Inova Schar Cancer Institute on the Inova Center for Personalized Health campus in Annandale, Va.
“The addition of proton therapy to our oncology services will bring our patients access to one of the most significant technology innovations in the treatment of cancer,” said Thomas Graves, vice president for cancer services and associate director for administration at the Inova Schar Cancer Institute. “The Institute will be housed at the Inova Center for Personalized Health, offering patients easy access from anywhere in Virginia and the Metro DC area. This advanced technology will be an excellent complement to the best in class oncology services we offer today.”
Gopal Bajaj, M.D., chairman and medical director of radiation oncology at the Inova Schar Cancer Institute, added: “Being able to provide such a powerful cancer treatment truly puts Inova’s radiation oncology department at the forefront of cancer treatment delivery. Proton therapy is an exciting alternative to traditional radiation treatment protocols, allowing us to treat many cancer patients more effectively, and often without the uncomfortable side effects that traditional treatments may cause. This technology will have a very positive impact on the thousands of people in our community who are touched by cancer.”
For more information: www.iba-worldwide.com
May 30, 2024 
